Live Breaking News & Updates on Targeted Alpha

Stay updated with breaking news from Targeted alpha. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

AdvanCell Appoints Anna Karmann, MD, PhD as Chief Medical Officer

SYDNEY (BUSINESS WIRE) #CMO AdvanCell, a clinical-stage radiopharmaceutical company developing a pipeline of Targeted Alpha Therapies for patients with cancer, today announced the appointment of ....

United States , San Francisco , Stanford University , Anna Karmann , Andrew Adamovich , Mckinsey Company , Tsinghua University , Bristol Myers Squibb , Maastricht University , University Medical Center Maastricht , Stanford University Hospital , Aachen University , Targeted Alpha Therapies , Chief Medical Officer , Investigational New Drug , Alpha Therapies , Targeted Alpha , Press Release ,

Orano Med Announces Appointment of Dr. Volker Wagner as Chief Medical Officer

Orano Med Announces Appointment of Dr. Volker Wagner as Chief Medical Officer
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United States , Julien Dodet , Clinical Development , Head Of Clinical Development Radiopharmaceuticals At Bayer , Targeted Alpha Therapies , Volker Wagner , Chief Medical , Vice President , Clinical Development Radiopharmaceuticals , Targeted Alpha , Medical Affairs , Internal Medicine , Medical Oncology , Orano Med ,

Orano Med Announces Appointment of Dr. Volker Wagner as Chief Medical Officer

PARIS (BUSINESS WIRE) Regulatory News:Orano Med (Orano group subsidiary), a leading innovator in the field of Targeted Alpha Therapies in oncology, is thrilled to announce the appointment of Dr. Volker Wagner MD PhD as its new Chief Medical Officer. Dr. Wagner brings a wealth of experience and expertise to the rol. ....

United States , Julien Dodet , Head Of Clinical Development Radiopharmaceuticals At Bayer , Clinical Development , Regulatory News , Targeted Alpha Therapies , Volker Wagner , Chief Medical , Vice President , Clinical Development Radiopharmaceuticals , Targeted Alpha , Medical Affairs , Internal Medicine , Medical Oncology , Orano Med ,

AdvanCell reaches milestone as first prostate cancer patient dosed with 212Pb-ADVC001

AdvanCell, a radiopharmaceutical company developing a pipeline of Targeted Alpha Therapies for cancer patients, today announced the first patient was treated with 212Pb-ADVC001, a Targeted Alpha Therapy in development for the treatment of PSMA-positive metastatic Castration-Resistant Prostate Cancer (mCRPC). ....

United States , Lily Ramsey , Uniklinik Essen , Andrew Adamovich , Ken Herrmann , University Of California Los Angeles , Prostate Cancer Foundation , Department Of Nuclear Medicine , Peter Maccallum Cancer Centre , University Of California San Francisco , Targeted Alpha Therapies , Targeted Alpha Therapy , Castration Resistant Prostate Cancer , Targeted Alpha , Advancell Advisory Board Member , Nuclear Medicine , Cancer Lethality Lead Collaboration , California Los Angeles , California San , Prostate Cancer , Clinical Trial ,

AdvanCell Announces First Patient Dosed in Phase I/II TheraPb Clinical Trial of 212Pb-ADVC001 in Metastatic Prostate Cancer

SYDNEY (BUSINESS WIRE) AdvanCell, a radiopharmaceutical company developing a pipeline of Targeted Alpha Therapies for cancer patients, today announced the first patient was treated with ....

United States , Uniklinik Essen , Andrew Adamovich , Ken Herrmann , University Of California Los Angeles , Prostate Cancer Foundation , University Of California San Francisco , Department Of Nuclear Medicine , Peter Maccallum Cancer Centre , Targeted Alpha Therapies , Targeted Alpha Therapy , Castration Resistant Prostate Cancer , Targeted Alpha , Advancell Advisory Board , Nuclear Medicine , Cancer Lethality Lead Collaboration , California Los Angeles , California San , Press Release ,